A better understanding of the pathophysiology of the acquired immune deficiency syndrome (AIDS) and the development of both antiviral treatment modalities and an efficacious vaccine for this disease are needed to control the current epidemic. Achieving these goals will be greatly facilitated by the development and exploitation of an animal model for AIDS. The only animal species which has been shown to be infectable with HTLV-III/LAV, the etiologic agent in AIDS, is thee chimpanzee. However, the chimpanzees have developed no signs of disease following infection with HTLV-III/LAV. This finding, as well as their endangered status, lack of ready availability and cost, make the use of the chimpanzee in AIDS research problematic. In the studies, a naturally occurring immunodeficiency syndrome of macaque monkeys with striking parallels to human AIDS has been defined. Its clinical and pathologic characteristics have been described, its transmissibility with tissue from affected animals has been demonstrated and a type C retrovirus has been isolated from these animals. This virus, STLV-III, is morphologically indistinguishable from and antigenically related to HTLV-III/LAV. STLV-III, upon inoculation into healthy juvenile rhesus monkeys, induces a disease characterized by immunologic dysfunction, including a decrease in T4+ PBL, and death due to wasting, opportunistic infections and primary retroviral enchephalitis. The work will further develop this AIDS model in macaque monkeys and exploit it to elucidate further the pathophysiology of AIDS. The experiments described include the characterization of the immune response to STLV-III, the characterization of events in the pathogenesis of STLV-III induced disease in macaque monkeys and the definition of variables in the STLV-III/macaque model.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI020729-05
Application #
3130524
Study Section
Immunological Sciences Study Section (IMS)
Project Start
1983-09-15
Project End
1989-11-30
Budget Start
1987-12-01
Budget End
1988-11-30
Support Year
5
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Manuel, Edwin R; Yeh, Wendy W; Seaman, Michael S et al. (2009) Dominant CD8+ T-lymphocyte responses suppress expansion of vaccine-elicited subdominant T lymphocytes in rhesus monkeys challenged with pathogenic simian-human immunodeficiency virus. J Virol 83:10028-35
Kim, Eun-Young; Veazey, Ronald S; Zahn, Roland et al. (2008) Contribution of CD8+ T cells to containment of viral replication and emergence of mutations in Mamu-A*01-restricted epitopes in Simian immunodeficiency virus-infected rhesus monkeys. J Virol 82:5631-5
Permar, Sallie R; Rao, Srinivas S; Sun, Yue et al. (2007) Clinical measles after measles virus challenge in simian immunodeficiency virus-infected measles virus-vaccinated rhesus monkeys. J Infect Dis 196:1784-93
Hasegawa, Atsuhiko; Moriya, Chikaya; Liu, Huining et al. (2007) Analysis of TCRalphabeta combinations used by simian immunodeficiency virus-specific CD8+ T cells in rhesus monkeys: implications for CTL immunodominance. J Immunol 178:3409-17
Manuel, Edwin R; Charini, William A; Sen, Pritha et al. (2006) Contribution of T-cell receptor repertoire breadth to the dominance of epitope-specific CD8+ T-lymphocyte responses. J Virol 80:12032-40
Newberg, Michael H; McEvers, Kimberly J; Gorgone, Darci A et al. (2006) Immunodomination in the evolution of dominant epitope-specific CD8+ T lymphocyte responses in simian immunodeficiency virus-infected rhesus monkeys. J Immunol 176:319-28
Margolin, David H; Saunders, Erika H; Bronfin, Benjamin et al. (2006) Germinal center function in the spleen during simian HIV infection in rhesus monkeys. J Immunol 177:1108-19
Yeh, Wendy W; Cale, Evan M; Jaru-Ampornpan, Pimkwan et al. (2006) Compensatory substitutions restore normal core assembly in simian immunodeficiency virus isolates with Gag epitope cytotoxic T-lymphocyte escape mutations. J Virol 80:8168-77
LaBonte, Michelle L; McKay, Paul F; Letvin, Norman L (2006) Evidence of NK cell dysfunction in SIV-infected rhesus monkeys: impairment of cytokine secretion and NKG2C/C2 expression. Eur J Immunol 36:2424-33
Barouch, Dan H; Powers, Jennifer; Truitt, Diana M et al. (2005) Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants. Nat Immunol 6:247-52

Showing the most recent 10 out of 140 publications